Gemelli Biotech
Raleigh
About Gemelli Biotech
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics. It strives to achieve a thriving global family of healthy individuals by unlocking the potential of the microbiome. The company is driven by its mission is to support the discovery of novel diagnostics and therapeutics for the human microbiome by bringing biotechnology innovations to market in a fiscally responsible and socially conscious way. The company was founded in 2018 and headquartered in North Carolina, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $28.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2022)
- Website: gemellibiotech.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/gemelli-biotech-3817 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.